The interpretation of the 2017 Acute Dialysis Quality Initiative Guidelines: precision continuous renal replacement therapy_West China Medical Journal

Authors：

HUANG Ronghshuang , ZHANG Ling ,  FU Ping

Department of Nephrology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding author：

FU Ping, Email: fupinghx@163.com

Keywords：

Continuous renal replacement therapy; Acute Dialysis Quality Initiative; Acute kidney injury; Interpretation of guidelines

DOI：

10.7507/1002-0179.201806111

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

In 2017, the Acute Dialysis Quality Initiative (ADQI) Consensus Group released a series of guidelines on the topic of "Precision Continuous Renal Replacement Therapy (CRRT)". The updated content in this guideline included four parts: patient selection and timing of CRRT, precision CRRT and solute control, precision fluid management in CRRT, and role of technology for the management of AKI in critically ill patients. This review will interpret the 2017 ADQI guidelines update in detail.

Citation： HUANG Ronghshuang, ZHANG Ling, FU Ping. The interpretation of the 2017 Acute Dialysis Quality Initiative Guidelines: precision continuous renal replacement therapy. West China Medical Journal, 2018, 33(7): 831-834. doi: 10.7507/1002-0179.201806111 Copy

1.	Kellum JA, Mehta RL, Angus DC, et al. The first international consensus conference on continuous renal replacement therapy. Kidney Int, 2002, 62(5): 1855-1863.
2.	Kellum JA, Ronco C. The 17th Acute Disease Quality Initiative International Consensus Conference: introducing precision renal replacement therapy. Blood Purif, 2016, 42(3): 221-223.
3.	Ostermann M, Joannidis M, Pani A, et al. Patient selection and timing of continuous renal replacement therapy. Blood Purif, 2016, 42(3): 224-237.
4.	Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl, 2012, 2（1）: 1-138.
5.	Hjortrup PB, Haase N, Wetterslev M, et al. Clinical review: predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients. Crit Care, 2013, 17(2): 211.
6.	Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis, 2009, 54(6): 1012-1024.
7.	Hoste EA, Mccullough PA, Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant, 2014, 29(11): 2054-2061.
8.	Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl, 1993, 41(41): S245-S251.
9.	Marshall MR, Golper TA, Shaver MJ, et al. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int, 2001, 60(2): 777-785.
10.	Kumar VA, Craig M, Depner TA, et al. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis, 2000, 36(2): 294-300.
11.	Zhang L, Yang J, Eastwood GM, et al. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis. Am J Kidney Dis, 2015, 66(2): 322-330.
12.	Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med, 2009, 37(9): 2576-2582.
13.	Rewa O, Mottes T, Bagshaw SM. Quality measures for acute kidney injury and continuous renal replacement therapy. Curr Opin Crit Care, 2015, 21(6): 490-499.
14.	Honoré PM, De Waele E, Jacobs R, et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif, 2013, 35(4): 279-284.
15.	Friedrich JO, Wald R, Bagshaw SM, et al. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care, 2012, 16(4): R146.
16.	Honore PM, Jacobs R, Joannes-Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J, 2013, 59(2): 99-106.
17.	Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision continuous renal replacement therapy and solute control. Blood Purif, 2016, 42(3): 238-247.
18.	Murugan R, Hoste E, Mehta RL, et al. Precision fluid management in continuous renal replacement therapy. Blood Purif, 2016, 42(3): 266-278.
19.	Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care, 2007, 11(4): 218.
20.	Kalantari K, Chang JN, Ronco C, et al. Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int, 2013, 83(6): 1017-1028.
21.	Cerdá J, Baldwin I, Honore PM, et al. Role of technology for the management of AKI in critically ill patients: from adoptive technology to precision continuous renal replacement therapy. Blood Purif, 2016, 42(3): 248-265.
22.	Cruz DN, Perazella MA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care, 2007, 11(2): R47.

1. Kellum JA, Mehta RL, Angus DC, et al. The first international consensus conference on continuous renal replacement therapy. Kidney Int, 2002, 62(5): 1855-1863.
2. Kellum JA, Ronco C. The 17th Acute Disease Quality Initiative International Consensus Conference: introducing precision renal replacement therapy. Blood Purif, 2016, 42(3): 221-223.
3. Ostermann M, Joannidis M, Pani A, et al. Patient selection and timing of continuous renal replacement therapy. Blood Purif, 2016, 42(3): 224-237.
4. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl, 2012, 2（1）: 1-138.
5. Hjortrup PB, Haase N, Wetterslev M, et al. Clinical review: predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients. Crit Care, 2013, 17(2): 211.
6. Haase M, Bellomo R, Devarajan P, et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis, 2009, 54(6): 1012-1024.
7. Hoste EA, Mccullough PA, Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant, 2014, 29(11): 2054-2061.
8. Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl, 1993, 41(41): S245-S251.
9. Marshall MR, Golper TA, Shaver MJ, et al. Sustained low-efficiency dialysis for critically ill patients requiring renal replacement therapy. Kidney Int, 2001, 60(2): 777-785.
10. Kumar VA, Craig M, Depner TA, et al. Extended daily dialysis: a new approach to renal replacement for acute renal failure in the intensive care unit. Am J Kidney Dis, 2000, 36(2): 294-300.
11. Zhang L, Yang J, Eastwood GM, et al. Extended daily dialysis versus continuous renal replacement therapy for acute kidney injury: a meta-analysis. Am J Kidney Dis, 2015, 66(2): 322-330.
12. Uchino S, Bellomo R, Morimatsu H, et al. Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med, 2009, 37(9): 2576-2582.
13. Rewa O, Mottes T, Bagshaw SM. Quality measures for acute kidney injury and continuous renal replacement therapy. Curr Opin Crit Care, 2015, 21(6): 490-499.
14. Honoré PM, De Waele E, Jacobs R, et al. Nutritional and metabolic alterations during continuous renal replacement therapy. Blood Purif, 2013, 35(4): 279-284.
15. Friedrich JO, Wald R, Bagshaw SM, et al. Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis. Crit Care, 2012, 16(4): R146.
16. Honore PM, Jacobs R, Joannes-Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J, 2013, 59(2): 99-106.
17. Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision continuous renal replacement therapy and solute control. Blood Purif, 2016, 42(3): 238-247.
18. Murugan R, Hoste E, Mehta RL, et al. Precision fluid management in continuous renal replacement therapy. Blood Purif, 2016, 42(3): 266-278.
19. Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care, 2007, 11(4): 218.
20. Kalantari K, Chang JN, Ronco C, et al. Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int, 2013, 83(6): 1017-1028.
21. Cerdá J, Baldwin I, Honore PM, et al. Role of technology for the management of AKI in critically ill patients: from adoptive technology to precision continuous renal replacement therapy. Blood Purif, 2016, 42(3): 248-265.
22. Cruz DN, Perazella MA, Bellomo R, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care, 2007, 11(2): R47.

Previous Article
Epigenetics and acute kidney injury
Next Article
Interpretation of the hotspots of Surviving Sepsis Campaign 2016

West China Medical Journal

The interpretation of the 2017 Acute Dialysis Quality Initiative Guidelines: precision continuous renal replacement therapy

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content